Certified by Founder Lodge
Vida Ventures, LLC
United States - Boston, Massachusetts
INVESTOR
1 Disclosed Funding Rounds $60,000,000
13 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Vida Ventures is a next-generation life sciences investment firm founded in 2017 by a group of scientists, physicians, entrepreneurs and investors passionate about building and funding breakt
| Company | Date | Round | Raised |
|---|---|---|---|
 Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
 Volastra Therapeutics |
March, 08 ,2023 | Series A | $60,000,000 |
 Quanta Therapeutics |
May, 23 ,2023 | Series D | $50,000,000 |
 Candid Therapeutics |
September, 10 ,2024 | Unknown | $370,000,000 |
 Kyverna Therapeutics |
August, 03 ,2023 | Series B | $60,000,000 |
 Antares Therapeutics |
June, 11 ,2025 | Series A | $117,000,000 |
 ReCode Therapeutics |
September, 20 ,2023 | Series B | $50,000,000 |
 Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
 Capstan Therapeutics |
March, 21 ,2024 | Series B | $175,000,000 |
 Alterome Therapeutics, Inc |
April, 09 ,2024 | Series B | $132,000,000 |
| Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
| Candid Therapeutics |
September, 10 ,2024 | Unknown | $370,000,000 |
| Antares Therapeutics |
June, 11 ,2025 | Series A | $117,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
